Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ACTIVATED PROTEIN C RESISTANCE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 194 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Quincampoix, JC; Legarff, M; Rittling, C; Andiva, S; Toulon, P
      Modification of the ProC (R) Global assay using dilution of patient plasmain factor V-depleted plasma as a screening assay for factor V Leiden mutation

      BLOOD COAGULATION & FIBRINOLYSIS
    2. Chitolie, A; Lawrie, AS; Mackie, IJ; Harrison, P; Machin, SJ
      The impact of oral anticoagulant therapy, factor VIII level and quality offactor V-deficient plasma on three commercial methods for activated protein C resistance

      BLOOD COAGULATION & FIBRINOLYSIS
    3. Cetin, M; Gucer, S; Serin, IS; Eser, B; Tayyar, M; Unal, A
      Activated protein C resistance in Turkish women with severe preeclampsia

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    4. Mousa, HA; Alfirevic, Z
      Thrombophilia and adverse pregnancy outcome

      CROATIAN MEDICAL JOURNAL
    5. Johnson, TM; El-Defrawy, S; Hodge, WG; Leonard, BC; Kertes, PJ; Taylor, SAM; Lillicrap, DP
      Prevalence of factor V Leiden and activated protein C resistance in central retinal vein occlusion

      RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
    6. Rai, R; Shlebak, A; Cohen, H; Backos, M; Holmes, Z; Marriott, K; Regan, L
      Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage

      HUMAN REPRODUCTION
    7. Scott, JA; Arnold, JJ; Currie, JM; Broadfoot, C; Davidson, M; Kelly, KF; Graham, A; Kirkpatrick, JNP; Greaves, M
      No excess of factor V : Q506 genotype but high prevalence of anticardiolipin antibodies without antiendothelial cell antibodies in retinal vein occlusion in young patients

      OPHTHALMOLOGICA
    8. Hoibraaten, E; Mowinckel, MC; de Ronde, H; Bertina, RM; Sandset, PM
      Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double-blind, placebo-controlled trial

      BRITISH JOURNAL OF HAEMATOLOGY
    9. Gaber, Y; Siemens, HJ; Schmeller, W
      Resistance to activated protein C due to factor V Leiden mutation: high prevalence in patients with post-thrombotic leg ulcers

      BRITISH JOURNAL OF DERMATOLOGY
    10. Spina, V; Aleandri, V; Morini, F
      The impact of the Factor V Leiden mutation on pregnancy

      HUMAN REPRODUCTION UPDATE
    11. Guis-Sabatier, S; Roudier, J; Arnoux, D; Rochwerger, A; Roux, H; Mattei, JP
      Antiphospholipid syndrome and factor V Leiden. Three cases with recurrent venous thrombosis

      JOINT BONE SPINE
    12. Bonduel, M; Hepner, M; Sciuccati, G; Torres, AF; Pieroni, G; Frontroth, JP
      Prothrombotic abnormalities in children with venous thromboembolism

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    13. Regeczy, N; Lakos, G; Balogh, I; Ajzner, E; Kiss, E; Szegedi, G
      The Leiden mutation of coagulation factor V in Hungarian SLE patients

      CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
    14. Sirvent, N; Fisher, F; el Hayek, T; Appert, A; Giudicelli, H; Griffet, J
      Absence of congenital prethrombotic disorders in children with Legg-Perthes disease

      JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B
    15. Younis, JS; Brenner, B; Ohel, G; Tal, J; Lanir, N; Ben-Ami, M
      Activated protein C resistance and factor V Leiden mutation can be associated with first- as well as second-trimester recurrent pregnancy loss

      AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
    16. Ivey, LM; Thom, JY; Ivey, JG; Baker, RI
      Determination of activated protein C resistance in anticoagulated and lupus positive patients

      BLOOD COAGULATION & FIBRINOLYSIS
    17. Toulon, P; Halbmeyer, WM; Hafner, G; Schmitt, Y; Randgard, B; Odpadlik, M; Van den Eynden, C; Wagner, C
      Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation

      BLOOD COAGULATION & FIBRINOLYSIS
    18. De Mitrio, V; Marino, R; Cicinelli, E; Galantino, P; Di Bari, L; Giannoccaro, F; De Pergola, G; Lapecorella, M; Schonauer, S; Schiraldi, O
      Beneficial effects of postmenopausal hormone replacement therapy with transdermal estradiol on sensitivity to activated protein C

      BLOOD COAGULATION & FIBRINOLYSIS
    19. Yetkin, E; Erbay, AR; Ayaz, S; Ileri, M; Yanik, A; Yetkin, G; Cehreli, S; Goksel, S
      Predictors of left ventricular thrombus formation in patients with anterior myocardial infarction: role of activated protein C resistance

      CORONARY ARTERY DISEASE
    20. Quehenberger, P; Handler, S; Mannhalter, C; Pabinger-Fasching, I; Speiser, W
      Evaluation of a highly specific functional test for the detection of factor V Leiden

      INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH
    21. Gowda, MS; Zucker, ML; Vacek, JL; Carriger, WL; Van Laeys, DL; Rachel, JM; Strope, BD
      Incidence of factor V Leiden in patients with acute myocardial infarction

      JOURNAL OF THROMBOSIS AND THROMBOLYSIS
    22. Kaplinsky, EJ; Favaloro, RR; Pombo, G; Perrone, SV; Vigliano, CA; Schnidt, JL; Boughen, RP
      Primary pulmonary artery sarcoma resembling chronic thromboembolic pulmonary disease

      EUROPEAN RESPIRATORY JOURNAL
    23. Demir, M; Vural, O; Sunar, H; Altun, A; Yorulmaz, F; Ozbay, G
      The prevalence of hereditary thrombophilia in the Trakya region of Turkey

      YONSEI MEDICAL JOURNAL
    24. Wu, JS; Zhou, ZZ; Li, XP; Li, XM; Chen, YH; Wang, GS; Wang, ZY
      Activated protein C resistance in antiphospholipid thrombosis syndrome

      CHINESE MEDICAL JOURNAL
    25. Kraus, JA; Stuper, BK; Nahser, HC; Klockgether, T; Berlit, P
      Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas

      JOURNAL OF NEUROLOGY
    26. Gillis, S; Lebenthal, A; Pogrebijsky, G; Levy, Y; Eldor, A; Eid, A
      Severe thrombotic complications associated with activated protein C resistance acquired by orthotopic liver transplantation

      HAEMOSTASIS
    27. Schutt, M; Kluter, H; Wiedemann, GJ; Richardt, G
      Coexistence of factor V Leiden and primary antiphospholipid syndrome: a patient with recurrent myocardial infarctions and thrombocytopenia

      ZEITSCHRIFT FUR KARDIOLOGIE
    28. Plurien, F; Le Lostec, Z; Pauwels, C; Welker, Y; Glaser, C; de Mazancourt, P; Peltier, JY; Mornet, P
      Cutaneous necrosis after alpha interferon injection uncovering activated Cprotein resistance: a case report.

      REVUE DE MEDECINE INTERNE
    29. Ara, JH; Rioja, RC; Rinon, C; Munoz, MSG; Caravaca, MLR; Miguel, JL
      Prevalence of genetic protrombotic factors (factor V Leiden and protrombinII20210 mutation) in glomerular nephropathies with or without thrombosis

      NEFROLOGIA
    30. Gomez, MR; Garcia, ES; Lacomba, DL; Marchante, I; Grande, L; Fernandez, MC
      Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    31. Egesel, T; Buyukasik, Y; Dundar, SV; Gurgey, A; Kirazli, S; Bayraktar, Y
      The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis

      JOURNAL OF CLINICAL GASTROENTEROLOGY
    32. Rimmer, JE; Cooper, PC; Brookfield, CJ; Preston, FE; Makris, M
      Evaluation of a global screening assay for the investigation of the protein C anticoagulant pathway

      CLINICAL AND LABORATORY HAEMATOLOGY
    33. Lensen, R; Rosendaal, F; Vandenbroucke, J; Bertina, R
      Factor V Leiden: the venous thrombotic risk in thrombophilic families

      BRITISH JOURNAL OF HAEMATOLOGY
    34. Fassett, MJ; Bohn, YC; Kuo, J; Wing, DA
      Longitudinal evaluation of activated protein C resistance among normal pregnancies of Hispanic women

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    35. Klingler, KR; Grote, S; Holzem, G; Wielckens, K
      Activated protein C (APC)-resistance: Automated detection of the point mutation at position 1691 in the factor V gene

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    36. Larsson, J; Hillarp, A; Olafsdottir, E; Bauer, B
      Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion

      ACTA OPHTHALMOLOGICA SCANDINAVICA
    37. Guven, D; Sayinalp, N; Kalayci, D; Dundar, S; Hasiripi, H
      Risk factors in central retinal vein occlusion and activated protein C resistance

      EUROPEAN JOURNAL OF OPHTHALMOLOGY
    38. Bucciarelli, P; Rosendaal, FR; Tripodi, A; Mannucci, PM; De Stefano, V; Palareti, G; Finazzi, G; Baudo, F; Quintavalla, R
      Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    39. Chaturvedi, S; Dzieczkowski, JS
      Protein S deficiency, activated protein C resistance and sticky platelet syndrome in a young woman with bilateral strokes

      CEREBROVASCULAR DISEASES
    40. Fisher, CM; Tew, K; Appleberg, M
      Prevalence and outcome of activated protein C resistance in patients afterperipheral arterial bypass grafts

      CARDIOVASCULAR SURGERY
    41. De Mitrio, V; Marino, R; Scaraggi, FA; Di Bari, L; Giannoccaro, F; Petronelli, M; Ranieri, P; Tannoia, N; Schiraldi, O
      Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation

      BLOOD COAGULATION & FIBRINOLYSIS
    42. Vargas, M; Soto, I; Pinto, CR; Urgelles, MF; Batalla, A; Rodriguez-Reguero, J; Cortina, A; Alvarez, V; Coto, E
      The prothrombin 20210A allele and the factor V Leiden are associated with venous thrombosis but not with early coronary artery disease

      BLOOD COAGULATION & FIBRINOLYSIS
    43. Saxena, R; Mohanty, S; Srivastava, A; Choudhry, VP; Kotwal, J
      Pathogenetic factors underlying juvenile deep vein thrombosis (DVT) in Indians

      EUROPEAN JOURNAL OF HAEMATOLOGY
    44. Kondaveeti, S; Hibberd, ML; Booy, R; Nadel, S; Levin, M
      Effect of the Factor V Leiden mutation on the severity of meningococcal disease

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    45. Koren, A; Zalman, L; Levin, C; Abu Hana, M; Mader, R; Shalev, S
      Venous thromboembolism, factor V Leiden, and methylenetetrahydrofolate reductase in a sickle cell anemia patient

      PEDIATRIC HEMATOLOGY AND ONCOLOGY
    46. Espana, F; Villa, P; Mira, Y; Grancha, S; Royo, M; Estelles, A; Vaya, A; Aznar, J
      Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion

      HAEMATOLOGICA
    47. Mello, G; Parretti, E; Martini, E; Mecacci, F; La Torre, P; Cioni, R; Lucchetti, R; Fedi, S; Gori, AM; Pepe, G; Prisco, D; Abbate, R
      Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies

      HAEMOSTASIS
    48. Tal, J; Schliamser, LM; Leibovitz, Z; Ohel, F; Attias, D
      A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure

      HUMAN REPRODUCTION
    49. Cretel, E; Cacoub, P; Amoura, Z; Hausfater, P; Elalamy, I; Richemond, J; Piette, JC
      Resistance to activated protein C and portal vein thrombosis: two cases and review of literature

      REVUE DE MEDECINE INTERNE
    50. Blachere, H; Dousset, V; Berger, O; Series, C; Jarnier, D; Caille, JM
      Cerebral panthrombophlebitis in a paucisymptomatic patient

      JOURNAL OF NEURORADIOLOGY
    51. Baker, RI; Eikelboom, J; Street, A
      Broadsheet number 53: Activated protein C resistance: diagnosis and clinical management

      PATHOLOGY
    52. Chaturvedi, S; Joshi, N; Dzieczkowski, J
      Activated protein C resistance in young African American patients with ischemic stroke

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    53. Barker, RA; Anderson, JR; Meyer, P; Dick, DJ; Scolding, NJ
      Microangiopathy of the brain and retina with hearing loss in a 50 year oldwoman: extending the spectrum of Susac's syndrome

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    54. Rulon, JJ; Cho, CG; Guerra, LL; Bux, RC; Gulley, ML
      Activated protein C resistance is uncommon in sudden death due to pulmonary embolism

      JOURNAL OF FORENSIC SCIENCES
    55. Otsuka, F; Amano, T; Uchida, H; Ogura, T; Makino, H
      A case of idiopathic deep vein thrombosis improved with glucocorticoid therapy

      HAEMATOLOGIA
    56. Heeb, MJ; Rehemtulla, A; Moussalli, M; Kojima, Y; Kaufman, RJ
      Importance of individual activated protein C cleavage site regions in coagulation Factor V for Factor Va inactivation and for Factor Xa activation

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    57. Palareti, G; Legnani, C; Frascaro, M; Flamigni, C; Gammi, L; Gola, G; Fuschini, G; Coccheri, S
      Screening for activated protein C resistance before oral contraceptive treatment: A pilot study

      CONTRACEPTION
    58. Donnelly, JG; Rock, GA
      Genetic determinants of heritable venous thrombosis: Genotyping methods for factor V-Leiden A1691G, methylenetetrahydrofolate reductase C677T, prothrombin G20210A mutation, and algorithms for venous thrombosis investigations

      CLINICAL BIOCHEMISTRY
    59. MacLean, RM; Feeney, GP; Bowley, SJ; Bowen, DJ; Worwood, M; Collins, PW
      Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?

      BRITISH JOURNAL OF HAEMATOLOGY
    60. Saxena, R; Mohanty, S; Jain, Y
      Activated protein C (APC) resistance in Indian children with thromboembolism

      BRITISH JOURNAL OF HAEMATOLOGY
    61. Ribeaudeau, F; Senet, P; Cayuela, JM; Fund, X; Paul, C; Robert, C; Scrobohaci, ML; Dubertret, L
      A prospective coagulation study including resistance to activated protein C and mutations in factors V and II in venous leg ulcers

      BRITISH JOURNAL OF DERMATOLOGY
    62. Rosing, J; Tans, G
      Effects of oral contraceptives on hemostasis and thrombosis

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    63. van Pampus, MG; Dekker, GA; Wolf, H; Huijgens, PC; Koopman, MMW; von Blomberg, BME; Buller, HR
      High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    64. Weiss, G
      Risk of venous thromboembolism with third-generation oral contraceptives: A review

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    65. Marcucci, R; Abbate, R; Fedi, S; Gori, AM; Brunelli, T; Bruni, V; Bucciantini, S; Micheli, S; Pepe, G; Prisco, D; Gensini, GF
      Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII : c levels

      AJCP. American journal of clinical pathology
    66. Gorman, TE; Arcot, AN; Baker, P; Prior, TW; Brandt, JT
      Prevalence of the factor V-Leiden mutation among autopsy patients with pulmonary thromboembolic disease using an improved method for factor V-Leiden detection

      AJCP. American journal of clinical pathology
    67. GOROG DA; RAKHIT R; PARUMS D; LAFFAN M; DAVIES GJ
      RAISED FACTOR-VIII IS ASSOCIATED WITH CORONARY THROMBOTIC EVENTS

      HEART
    68. SZCZEPANSKI M; CIESLAK E; GARDAS A; BAUER A; MAJKOWSKI J
      PREVALENCE OF HIGH IGM ANTICARDIOLIPINS IN PATIENTS WITH ISCHEMIC STROKE

      European journal of neurology
    69. MATTSON JC; CRISAN D
      INHERITED THROMBOPHILIA DUE TO FACTOR-V-LEIDEN MUTATION

      Molecular diagnosis
    70. RUIZARGUELLES GJ
      THE ACTIVATED PROTEIN-C RESISTANCE PHENOTYPE OF THE ANTIPHOSPHOLIPID SYNDROME MAY FOLLOW A RELAPSING COURSE

      Clinical and applied thrombosis/hemostasis
    71. YILDIZ BO; ORAN B; BUYUKASIK Y; HAZNEDAROGLU IC; CEKIRGE S; KIRAZLI S
      ACUTE BUDD-CHIARI SYNDROME-ASSOCIATED WITH ACTIVATED PROTEIN-C RESISTANCE DURING INTRAVENOUS ANTICOAGULANT TREATMENT

      Clinical and applied thrombosis/hemostasis
    72. OVER HH; ULGEN S; TUGLULAR T; TEZEL A; AVSAR E; GEYIK G; BASGUL S; SAYHAN N; ULUSOY N; KALAYCI C; TOZUN N
      THROMBOPHILIA AND INFLAMMATORY BOWEL-DISEASE - DOES FACTOR-V MUTATIONHAVE A ROLE

      European journal of gastroenterology & hepatology
    73. BENNET L; ODEBERG H
      RESISTANCE TO ACTIVATED PROTEIN-C, HIGHLY PREVALENT AMONGST USERS OF ORAL-CONTRACEPTIVES WITH VENOUS THROMBOEMBOLISM

      Journal of internal medicine
    74. Pineo, GF; Hull, RD
      Thrombophilia: disorders predisposing to venous thromboembolism

      BAILLIERES CLINICAL HAEMATOLOGY
    75. DELUCIA D; DALESSIO D; PEZZELLA S; MAISTO G; DIMAURO C; MAROTTA R; DELGIUDICE V; IACOVIELLO L
      A HYPERCOAGULABLE STATE IN ACTIVATED PROTEIN-C RESISTANT PATIENTS WITH ISCHEMIC STROKE

      International journal of clinical & laboratory research
    76. BATHELIER C; CHAMPENOIS T; LUCOTTE G
      ARMS TEST FOR DIAGNOSIS OF FACTOR-V-LEIDEN MUTATION AND ALLELE FREQUENCIES IN FRANCE

      Molecular and cellular probes
    77. Guermazi, S; M'Rad, S; Lamloum, M; Houman, MH; Hamza, M; Ben Dridi, M; Miled, M; Dellagi, K
      Active protein C resistance in Behcet's disease.

      PATHOLOGIE BIOLOGIE
    78. ESSEX DW; WYNN SS; JIN DK
      LATE-ONSET WARFARIN-INDUCED SKIN NECROSIS - CASE-REPORT AND REVIEW OFTHE LITERATURE

      American journal of hematology
    79. SIFONTES MT; NUSS R; HUNGER SP; WATERS J; JACOBSON LJ; MANCOJOHNSON M
      ACTIVATED PROTEIN-C RESISTANCE AND THE FACTOR-V-LEIDEN MUTATION IN CHILDREN WITH THROMBOSIS

      American journal of hematology
    80. WEIH M; VETTER B; ZIEMER S; MEHRAEIN S; VALDUEZA JM; KOSCIELNY J; KULOZIK AE; EINHAUPL KM
      INCREASED RATE OF FACTOR-V-LEIDEN MUTATION IN PATIENTS WITH CEREBRAL VENOUS THROMBOSIS

      Journal of neurology
    81. KRAUS JA; STUPER BK; BERLIT P
      ASSOCIATION OF RESISTANCE TO ACTIVATED PROTEIN-C AND DURAL ARTERIOVENOUS-FISTULAS

      Journal of neurology
    82. D'Amico, D; Moschiano, F; Leone, M; Ariano, C; Ciusani, E; Erba, N; Grazzi, L; Ferraris, A; Schieroni, F; Bussone, G
      Genetic abnormalities of the protein C system: shared risk factors in young adults with migraine with aura and with ischemic stroke?

      CEPHALALGIA
    83. PICILLO U; DELUCIA D; PALATIELLO E; SCUOTTO A; MARCIALIS MR; PEZZELLA S; TIRRI G
      ASSOCIATION OF PRIMARY ANTIPHOSPHOLIPID SYNDROME WITH INHERITED ACTIVATED PROTEIN-C RESISTANCE

      Journal of rheumatology
    84. Bots, ML; van Kooten, F; Breteler, MMB; Slagboom, PE; Hofman, A; Haverkate, F; Meijer, P; Koudstaal, PJ; Grobbee, DE; Kluft, C
      Response to activated protein c in subjects with and without dementia - The Dutch vascular factors in dementia study

      HAEMOSTASIS
    85. Petaja, J; Hakala, L; Rasi, V; Griffin, JH
      Circulating activated protein C in subjects with heterozygous GIn506-factor V

      HAEMOSTASIS
    86. ZAUBER NP; SABBATHSOLITARE M; RAJORIA G; MOGAN G
      FACTOR-V-LEIDEN MUTATION IS NOT INCREASED IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE

      Journal of clinical gastroenterology
    87. HENEGHAN MA; CLEARY B; MURRAY M; OGORMAN TA; MCCARTHY CF
      ACTIVATED PROTEIN-C RESISTANCE, THROMBOPHILIA, AND INFLAMMATORY BOWEL-DISEASE

      Digestive diseases and sciences
    88. De Moerloose, P; Bounameaux, HR; Mannucci, PM
      Screening tests for thrombophilic patients: Which tests, for which patient, by whom, when, and why?

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    89. De Stefano, V; Chiusolo, P; Paciaroni, K; Leone, G
      Epidemiology of factor V Leiden: Clinical implications

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    90. Francis, JL
      Laboratory investigation of hypercoagulability

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    91. CHATURVEDI S
      COAGULATION ABNORMALITIES IN ADULTS WITH CRYPTOGENIC STROKE AND PATENT FORAMEN OVALE

      Journal of the neurological sciences
    92. CHATURVEDI S; DZIECZKOWSKI J
      MULTIPLE HEMOSTATIC ABNORMALITIES IN YOUNG-ADULTS WITH ACTIVATED PROTEIN-C RESISTANCE AND CEREBRAL-ISCHEMIA

      Journal of the neurological sciences
    93. CROOKSTON KP; HENDERSON R; CHANDLER WL
      FALSE-NEGATIVE FACTOR-V-LEIDEN ASSAY FOLLOWING ALLOGENEIC STEM-CELL TRANSPLANT

      British Journal of Haematology
    94. HOOPER WC; EVATT BL
      THE ROLE OF ACTIVATED PROTEIN-C RESISTANCE IN THE PATHOGENESIS OF VENOUS THROMBOSIS

      The American journal of the medical sciences
    95. Wiener-Megnagi, Z; Ben-Shlomo, I; Goldberg, Y; Shalev, E
      Resistance to activated protein C and the Leiden mutation: High prevalencein patients with abruptio placentae

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    96. DUMENCO LL; BLAIR AJ; SWEENEY JD
      THE RESULTS OF DIAGNOSTIC STUDIES FOR THROMBOPHILIA IN A LARGE GROUP OF PATIENTS WITH A PERSONAL OR FAMILY HISTORY OF THROMBOSIS

      AJCP. American journal of clinical pathology
    97. PEDERSEN OD; GRAM J; JESPERSEN J
      PLASMA RESISTANCE TO ACTIVATED PROTEIN-C REGULATES THE ACTIVATION OF COAGULATION INDUCED BY THROMBOLYSIS IN PATIENTS WITH ISCHEMIC-HEART-DISEASE

      HEART
    98. ARTEMIS N; HELIOPOULOS J; MAKRIS P; PIPERIDOU H; MILONAS J
      BILATERAL CENTRAL RETINAL ARTERY OCCLUSIONS IN A PATIENT WITH ACTIVATED PROTEIN-C RESISTANCE

      European journal of neurology
    99. KALAFATIS M; MANN KG
      FACTOR-V-LEIDEN AND THROMBOPHILIA

      Arteriosclerosis, thrombosis, and vascular biology
    100. MEYER T; GARCIA M; HELMS E; FRANCIS DA; FRANCIS JL
      TEMPORAL CHANGES IN THE ACTIVATED PROTEIN-C RESISTANCE RATIO IN A HETEROZYGOTE FOR FACTOR-V-LEIDEN ARE ABOLISHED BY DILUTION IN FACTOR V-DEFICIENT PLASMA

      Clinical and applied thrombosis/hemostasis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 23:41:04